Literature DB >> 7777059

Glucosylation of Rho proteins by Clostridium difficile toxin B.

I Just1, J Selzer, M Wilm, C von Eichel-Streiber, M Mann, K Aktories.   

Abstract

Toxin A and B, the major virulence factors of Clostridium difficile, are the causative agents of antibiotic-associated pseudomembranous colitis. In cultured cell lines their potent cytotoxicity results from their ability to induce disaggregation of the microfilament cytoskeleton. Toxin B acts on the low-molecular-mass GTPase RhoA, which is involved in the regulation of the actin cytoskeleton. We report here that toxin B catalyses the incorporation of up to one mole of glucose per mole of RhoA at the amino acid threonine at position 37. The modification was identified and localized by tandem electrospray mass spectrometry. UDP-glucose selectively serves as cosubstrate for the monoglucosylation reaction catalysed by toxin B. Microinjection of RhoA previously glucosylated by toxin B into monolayer cells caused disaggregation of actin filaments, indicating a dominant-negative activity of glucosylated RhoA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777059     DOI: 10.1038/375500a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  321 in total

1.  The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal.

Authors:  M Le Gall; J C Chambard; J P Breittmayer; D Grall; J Pouysségur; E Van Obberghen-Schilling
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

2.  p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.

Authors:  M Warny; A C Keates; S Keates; I Castagliuolo; J K Zacks; S Aboudola; A Qamar; C Pothoulakis; J T LaMont; C P Kelly
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.

Authors:  H Genth; J Selzer; C Busch; J Dumbach; F Hofmann; K Aktories; I Just
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Polarization of chemoattractant receptor signaling during neutrophil chemotaxis.

Authors:  G Servant; O D Weiner; P Herzmark; T Balla; J W Sedat; H R Bourne
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

5.  Synergistic activation of JNK/SAPK by interleukin-1 and platelet-derived growth factor is independent of Rac and Cdc42.

Authors:  W Davis; L R Stephens; P T Hawkins; J Saklatvala
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

6.  Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction.

Authors:  I Sorg; U M Goehring; K Aktories; G Schmidt
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  Activation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cells.

Authors:  C Fiorentini; L Falzano; A Fabbri; A Stringaro; M Logozzi; S Travaglione; S Contamin; G Arancia; W Malorni; S Fais
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

8.  Regulation of somatodendritic GABAA receptor channels in rat hippocampal neurons: evidence for a role of the small GTPase Rac1.

Authors:  D K Meyer; C Olenik; F Hofmann; H Barth; J Leemhuis; I Brünig; K Aktories; W Nörenberg
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

Review 9.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation.

Authors:  J Berkes; V K Viswanathan; S D Savkovic; G Hecht
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

10.  Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells.

Authors:  Gregor Guttenberg; Sven Hornei; Thomas Jank; Carsten Schwan; Wei Lü; Oliver Einsle; Panagiotis Papatheodorou; Klaus Aktories
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.